Labiotech.eu

News and Trends 30 Aug 2016

New non-amphetaminic ADHD drug ‘speeds’ into Phase II

ADHD is believed to affect up to 7% of people worldwide, but some common therapies bear a shocking resemblance to Speed. A new drug from NLS, Mazindol, just entered Phase II and could set a new non-amphetaminic standard. The treatment of Attention Deficit Hyperactive Disorder (ADHD) is hotly debated in the US, were almost 10% […]

August 30, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 30 Aug 2016

Mice made Transparent to reveal Brain and Blood Networks

uDISCO could be the name of Munich’s newest, hottest club. Indeed, it stands for ‘ultimate DISCO’ and boasts mesmerizing green lights. But it’s actually something much more exciting: it’s a new method that renders mice transparent to improve anatomical imaging. A team of researchers headed by Prof. Ali Ertürk at Ludwig Maximilian University in Munich, […]

August 30, 2016 - 2 minutesmins - By Evelyn Warner

biologics 2015 blockbusters best selling drugs

News and Trends 30 Aug 2016

Top 10 Best-selling Biologicals of 2015

Biological drugs have revolutionised disease treatment and their developers have made a killing along the way. We take a look at the top selling biologicals of 2015 – and if they are on their way in or out. Since the beginning of modern biotechnology, with Genentech’s recombinant DNA breakthrough, biologicals have created alternative and more specific treatments for […]

August 30, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 29 Aug 2016

Sanofi’s Phase III Results could make Praluent the next Blockbuster Cholesterol Drug

If you’re only just recovering from Pfizer’s inescapable ad campaign for Lipitor, brace yourself: Sanofi and Regeneron are poised to introduce its successor, Praluent (alirocumab), following its excellent Phase III results. Heart disease is the leading cause of death in Americans over the age of 35, and it contributes significantly to the global mortality rate. […]

August 29, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 29 Aug 2016

Maybe you don’t need Chemo: NEJM hails MammaPrint as Diagnostic Tool

About 46% of women with breast cancer may not need chemotherapy. An article in the New England Journal of Medicine describes a new assay from Agendia, MammaPrint, could save them the pain of this toxic treatment. Personalizing medicine is a major focus in the development of ever more precise treatments, and it is particularly relevant […]

August 29, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 27 Aug 2016

European BioArtists featured in Online Exhibition by Pioneering New York Platform

SciArt Center, a New York-based organisation for the collaboration of scientists and artists on all manner of endeavours, has just opened an online exhibition of bioart featuring a number of European artists. The exhibit, titled, “EmBodied,” explores the understanding of our souls through the human body. The human body is the best picture to the […]

August 27, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 26 Aug 2016

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

F-star’s “plug-and-play” technology can turn any existing antibody into a full-size bispecific antibody. Denali has recognized its potential use for drug delivery to the CNS and inked a deal with the UK-based company for almost €1B. Denali (US) and F-Star (UK) have struck a deal to develop F-star’s Modular Antibody Technology™ for the generation of […]

August 26, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 26 Aug 2016

Antibodyomes for faster Discovery of Biologicals, with Memo Therapeutics

After delighting ourselves with fabulous French gastronomy in Nancy, it’s time to say our farewells and head to the next border. Basel is our final destination. Our goal? Get to know a bit more of Swiss-based company Memo Therapeutics, our Biotech of the Week. City: Basel, Switzerland Founded: 2010 Employees: 10 Financial Data: €2.1M Total Raised (as of […]

August 26, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 26 Aug 2016

UCL & Cell Medica start a TCR Collaboration towards a Cancer Cure

Bridging the divide between academia and industry, Cell Medica and UCL are teaming up on TCR engineering in the effort to find a cancer cure. Not many details were disclosed, but cancer now has a new force to reckon with. For the most part, scientists thrive on competition, and what better fuel is there than […]

August 26, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 25 Aug 2016

Daratumumab could Knock Multiple Myeloma Down and Out: EMA will Judge

Multiple Myeloma is almost a death sentence: you probably won’t make it through five more years, and even if current treatments send it to remission, your chances of relapse are high. Janssen’s new drug, Darzalex (daratumumab), has shown promise to knock MM down and out for good in Phase III trails, and it now awaits […]

August 25, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 25 Aug 2016

Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis

After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development of filgotinib for rheumatoid arthritis. Phase III trials have officially begun! Galapagos is making progress as its rheumatoid arthritis drug, filgotinib, enters Phase III clinical trials. This comes after a major setback when its deal with AbbVie fell through last fall. It’s not […]

August 25, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 24 Aug 2016

While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’

Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen to unprecedented levels in Europe. Gilead’s HIV-1 ‘vaccine’, Truvada, has just been approved for marketing in Europe to stop its spread. The year 2014 brought the highest number of new HIV diagnoses ever recorded in Europe, 94% of which were […]

August 24, 2016 - 2 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New non-amphetaminic ADHD drug ‘speeds’ into Phase II

Mice made Transparent to reveal Brain and Blood Networks

Top 10 Best-selling Biologicals of 2015

Sanofi’s Phase III Results could make Praluent the next Blockbuster Cholesterol Drug

Maybe you don’t need Chemo: NEJM hails MammaPrint as Diagnostic Tool

European BioArtists featured in Online Exhibition by Pioneering New York Platform

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

Antibodyomes for faster Discovery of Biologicals, with Memo Therapeutics

UCL & Cell Medica start a TCR Collaboration towards a Cancer Cure

Daratumumab could Knock Multiple Myeloma Down and Out: EMA will Judge

Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis

While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!